Study: Medical robotics industry will hit $1.3B in 2016

Advances in robotic capabilities, combined with the improving economic environment for medical services delivery and payments, are driving demand for surgical, assistive and telemedicine-based robots, according to ABI Research.

A report by ABI, “Healthcare and Medical Robots,” predicts the global market for medical robotics will grow from just under $790 million in 2011 to nearly $1.3 billion in 2016, driven largely by sales of advanced surgical robots and related automated radiosurgical systems.

However, the initial cost of implementing these systems remains a barrier, particularly for smaller medical organizations. In addition, robotic systems for medical care and treatment require thorough clinical testing and trials as part of the regulatory approvals process. This can raise these products’ prices and draw out the time it takes to get them to market, according to ABI.

The market is also limited by the number of qualified medical institutions or practitioners who can utilize these devices. Smaller organizations simply may not be able to afford the up-front capital expenditure associated with robots, which can cost anywhere from tens of thousands of dollars to more than $4 million per unit, the research firm stated.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.